Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 7;6(1):32.
doi: 10.1186/s40169-017-0162-5.

Profiling of cardio-metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study

Eric Adua  1 , Peter Roberts  1 , Samuel Asamoah Sakyi  2 , Francis Agyemang Yeboah  2 , Albert Dompreh  3 , Kwasi Frimpong  1 , Enoch Odame Anto  1 , Wei Wang  4
Affiliations

Profiling of cardio-metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study

Eric Adua et al. Clin Transl Med. .

Abstract

Background: Type II diabetes mellitus (T2DM) is complicated by multiple cardio-metabolic risk factors. Controlling these factors requires lifestyle modifications alongside utilisation of anti-diabetic medications. Different glucose lowering [(biguanides (BIGs), sulfonylureas (SUAs), thiazolidinediones (TNZ)], lipid lowering (statins), and anti-hypertensive medicines [angiotensin converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), angiotensin II receptor blockers (ARBs) and central acting drugs (CADs)] have been approved for controlling hyperglycaemia, dyslipidaemia and hypertension respectively. Here, we examined factors that characterise T2DM and explored the response to medication therapy among T2DM patients.

Methods: This prospective cohort study recruited 241 T2DM patients reporting at a clinic in Ghana, from January through to August, 2016. Each patient's demographic, medications and anthropometric data was obtained while information on medication adherence was captured using Morisky adherence scale-8 (MMAS-8). Fasting blood samples were collected for biochemical analysis.

Results: The mean age of participants was 57.82 years for baseline and six-month follow-up. Physical activity differed at baseline and follow up (p < 0.05) but not body mass index (BMI). BIG alone, or in combination with SUA and TNZ did not improve glycaemic status at follow up (p > 0.05). Many participants using either ACEI or ARB were able to control their blood pressures. Among dyslipidaemia patients under statin treatment, there was an improved lipid profile at follow-up.

Conclusions: Statin medications are effective for reducing dyslipidaemia in T2DM patients. However, control of modifiable risk factors, particularly blood glucose and to a lesser degree blood pressure is suboptimal. Addressing these will require concomitant interventions including education on medication adherence and correct dietary plans, lifestyle modifications and physical activity.

Keywords: Anti-diabetic medications; Ghana; Hypertension; Risk factors; Type II diabetes mellitus.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Category of medications utilised by T2DM patients
See this image and copyright information in PMC

References

    1. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Rastas M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–1350. doi: 10.1056/NEJM200105033441801. - DOI - PubMed
    1. International Diabetes Federation: IDF Diabetes Atlas 2015. http://www.diabetesatlas.org/resources/2015-atlas.html. Accessed 04 Oct 2016
    1. The World Health Organisation: The Diabetes epidemiology 2014. http://www.who.int/mediacentre/factsheets/fs312/en/accessed. Accessed 14 Feb 2015
    1. Epstein FH, Shepherd PR, Kahn BB. Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999;341(4):248–257. doi: 10.1056/NEJM199907223410406. - DOI - PubMed
    1. Danquah I, Bedu-Addo G, Terpe KJ, Micah F, Amoako YA, Awuku YA, Mockenhaupt FP. Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health. 2012;12(210):1–8. - PMC - PubMed

LinkOut - more resources